desogestrel/ethinyl estradiol and ethinyl estradiol

DRUG2 trials

Sponsors

Teva Branded Pharmaceutical Products R&D, Inc.

Conditions

Follicle CountFollicle DevelopmentFollicle SizeHemostasisOral ContraceptiveOvarian Follicle

Phase 1

A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives

CompletedNCT01291004

Teva Branded Pharmaceutical Products R&D, Inc.Follicle Count, Follicle Development, Follicle Size +2

Start: 2011-01-31End: 2012-03-31Updated: 2021-12-08

Phase 2

A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women

CompletedNCT01388491

Teva Branded Pharmaceutical Products R&D, Inc.Hemostasis, Oral Contraceptive

Start: 2011-10-31End: 2012-09-30Updated: 2021-12-06